The intellectual base and research fronts of IL-18: A bibliometric review of the literature from WoSCC (2012–2022)

Abstract

Interleukin-18 (IL-18) is a vital pro-inflammatory cytokine crucial for immune regulation. Despite its significance, bibliometric analysis in this field is lacking. This study aims to quantitatively and qualitatively assess IL-18 research to construct its intellectual base and predict future hotspots. We conducted a thorough search on the Web of Science Core Collection for relevant publications between 1 January 2012 and 31 December 2022. English-language articles and reviews were included. Visual analysis was performed using various tools including VOSviewer, Citespace, and Microsoft Excel. Our analysis covers interleukin-18 (IL-18) literature from 2012 to 2022, exploring research trends comprehensively. Key institutions like Yale University and Shanghai Jiao Tong University emerged as significant contributors. Prolific authors such as Kanneganti and Dinarello made notable contributions. Main focus areas included biology, medicine, and immunology. Co-citation analysis highlighted influential works like Jianjin Shi. Hotspot keyword frequency cluster analysis revealed emerging themes like pyroptosis and psoriasis. Gene co-occurrence clustering identified genes associated with immune regulation and inflammation. GO and KEGG pathway enrichment analysis provided insights into IL-18-related biological processes and pathways. Protein–protein interaction networks identified core proteins such as IL10 and TNF. Association disease analysis linked IL-18 to various inflammatory, autoimmune, and metabolic disorders. This bibliometric review offers insights into IL-18 research trends over the past decade, guiding future investigations and serving as a reference for researchers in this field.

References

[1] DinarelloCA, NovickD, PurenAJ, et al. Overview of interleukin-18:more than an interferon-gamma inducing factor. J Leukoc Biol. 1998;63(6):658-664.

[2] YasudaK, Nakanishi K, TsutsuiH. Interleukin-18 in health and disease. Int J Mol Sci. 2019;20(3):649.

[3] KrishnanSM, SobeyCG, LatzE, Mansell A, DrummondGR. IL-1β and IL-18:inflammatory markers or mediators of hypertension? Br J Pharmacol. 2014;171(24):5589-5602.

[4] RexDAB, Nupur Agarwal TS, PrasadK, et al. A comprehensive pathway map of IL-18-mediated signalling. J Cell Commun Signal. 2020;14(2):257-266.

[5] ZhouT, DamskyW, WeizmanO-E, et al. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. Nature. 2020;583:609-614.

[6] LiX, CuiW, HullL, Wang L, YuT, XiaoM. IL-18 binding protein (IL-18BP) as a novel radiation countermeasure after radiation exposure in mice. Sci Rep. 2020;10(1):18674.

[7] DinarelloCA, NovickD, KimS, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013;8(4):289.

[8] DixonKO, Kuchroo VK. IL-18:throwing off the shackles to boost anti-tumor immunity. Cell Research. 2020;30:831-832.

[9] MejiaC, WuM, ZhangY, Kajikawa Y. Exploring topics in bibliometric research through citation networks and semantic analysis. Front Res Metr Anal. 2021;6:742311.

[10] SilvaR, RochaRS, RamosGLPA, et al. What are the challenges for ohmic heating in the food industry? Insights of a bibliometric analysis. Food Res Int. 2022;157:111272.

[11] Farias da CruzM, Baraúna Magno M, Alves JuralL, et al. Probiotics and dairy products in dentistry: a bibliometric and critical review of randomized clinical trials. Food Res Int. 2022;157:111228.

[12] de SouzaHF, Monteiro GF, BogázLT, et al. Bibliometric analysis of water kefir and milk kefir in probiotic foods from 2013 to 2022:a critical review of recent applications and prospects. Food Res Int. 2024;175:113716.

[13] RusuDM, Mândru SD, BirişCM, PetraşcuOL, Morariu F, Ianosi-Andreeva-Dimitrova A. Soft robotics: a systematic review and bibliometric analysis. Micromachines (Basel). 2023;14(2):359.

[14] MaC, SuH, LiH. Global research trends on prostate diseases and erectile dysfunction: a bibliometric and visualized study. Front Oncol. 2020;10:627891.

[15] ChenC. CiteSpace II: detecting and visualizing emerging trends. J Am Soc Inform Sci Technol. 2006;57(3):359-377.

[16] ArrudaH, SilvaER, LessaM, et al. VOSviewer and Bibliometrix. Informatica. 2022;46(3):392-395.

[17] PanX, YanE, CuiM, et al. Examining the usage, citation, and diffusion patterns of bibliometric mapping software: a comparative study of three tools. J Inform. 2018;12(2):481-493.

[18] WickhamH. ggplot2:Elegant Graphics for Data Analysis. Springer-Verlag; 2009.

[19] LandyE, CarolH, RingA, Canna S. Biological and clinical roles of IL-18 in inflammatory diseases. Nat Rev Rheumatol. 2024;20:33-47.

[20] KanaiT, KamadaN, HisamatsuT. Clinical strategies for the blockade of IL-18 in inflammatory bowel diseases. Curr Drug. 2013;14(12):1392-1399.

[21] Ferreira SdaC, Chachá SG, SouzaFF, et al. IL-18, TNF, and IFN-γ alleles and genotypes are associated with susceptibility to chronic hepatitis B infection and severity of liver injury. J Med. 2015;87(10):1689-1696.

[22] ChenPK, WeySJ, ChenDY. Interleukin-18:a biomarker with therapeutic potential in adult-onset still’s disease. Expert Rev Clin Immunol. 2022;18(8):823-833.

[23] McInnesIB, LiewFY, GracieJA. Interleukin-18:a therapeutic target in rheumatoid arthritis? Arthritis Res Ther. 2005;7(1):38-41.

[24] ShanNN, ZhuXJ, WangQ, et al. High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpura. Haematologica. 2009;94(11):1603-1607.

[25] HuB, RenJ, LuoY, et al. Augmentation of antitumor immunity by human and mouse CAR T cells secreting IL-18. Cell Rep. 2017;20(13):3025-3033.

[26] O’BrienLC, Mezzaroma E, Van TassellBW, et al. Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure. Mol med. 2014;20(1):221-229.

[27] ForouzandehM, BesenJ, KeaneRW, de Rivero VaccariJP. The inflammasome signaling proteins ASC and IL-18 as biomarkers of psoriasis. Front Pharmacol. 2020;11:1238.

[28] ChenJL, NiuXL, GaoYL, et al. IL-18 knockout alleviates atopic dermatitis-like skin lesions induced by MC903 in a mouse model. Int J Mol med. 2020;46(2):880-888.

[29] AringerM. Inflammatory markers in systemic lupus erythematosus. J Autoimmun. 2020;110:102374.

[30] KimM, KimKE, JungHY, et al. Recombinant erythroid differentiation regulator 1 inhibits both inflammation and angiogenesis in a mouse model of rosacea. Exp Dermatol. 2015;24(9):680-685.

[31] ShamsabadiRM, BasafaS, YarahmadiR, et al. Elevated expression of NLRP1 and IPAF are related to Oral pemphigus vulgaris pathogenesis. Inflammation. 2015;38(1):205-208.

[32] LukensJR, GurungP, ShawPJ, et al. The NLRP12 sensor negatively regulates autoinflammatory disease by modulating Interleukin-4 production in T cells. Immunity. 2015;42(4):654-664.

[33] NeteaMG, Joosten LAB, LewisE, et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat med. 2006;12(6):650-656.

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.